XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Operations - USD ($)
shares in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]      
Net revenue $ 740,840,000 $ 932,472,000 $ 1,168,073,000
Cost of revenue 491,588,000 681,923,000 802,236,000
Gross profit 249,252,000 250,549,000 365,837,000
Operating expenses:      
Research and development 83,295,000 88,443,000 92,967,000
Sales and marketing 127,778,000 139,675,000 145,961,000
General and administrative 66,243,000 56,316,000 59,659,000
Goodwill impairment 0 44,442,000 0
Intangibles impairment 1,071,000 0 0
Other operating expenses, net 4,140,000 4,597,000 653,000
Total operating expenses 282,527,000 333,473,000 299,240,000
Income (loss) from operations (33,275,000) (82,924,000) 66,597,000
Other income (expenses), net [1] 14,139,000 902,000 (1,093,000)
Income (loss) before income taxes (19,136,000) (82,022,000) 65,504,000
Provision for (benefit from) income taxes 85,631,000 (13,035,000) 16,117,000
Net income (loss) $ (104,767,000) $ (68,987,000) $ 49,387,000
Net income (loss) per share      
Basic $ (3.57) $ (2.38) $ 1.63
Diluted $ (3.57) $ (2.38) $ 1.59
Weighted average shares used to compute net income (loss) per share:      
Basic 29,355 29,007 30,241
Diluted 29,355 29,007 31,002
[1] Amounts included gain/(loss), net from litigation settlement of $6.0 million for the year ended December 31, 2023, and gain/(loss), net from derivatives not designated as hedging instruments of $0.3 million, $2.7 million and $4.2 million, for the years ended December 31, 2023, 2022 and 2021, respectively.